Skip to main content
Fig. 4 | Cost Effectiveness and Resource Allocation

Fig. 4

From: Cost-utility analysis of olaparib assisted targeted therapy for BRCA mutation HER2-negative early breast cancer in China and in the United States

Fig. 4

Tornado diagram of single factor sensitivity analysis of the Markov model in China (A) and in the United States (B). X-axis Incremental cost-effectiveness ratio (ICER), measured in RMB/QALY for China and USD/QALY for the United States. Y-axis Parameters being analyzed (e.g., drug cost, utility values, transition probabilities). Bars: The length of each bar represents the range of ICER values when the parameter is varied. The longer the bar, the greater the impact of that parameter on the results

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us